HALO insider transaction filings

HALOZYME THERAPEUTICS, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-19. Screen HALO transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-194Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $18.41 · Sale (S): 900 @ $98.96 · Sale (S): 500 @ $100.46 · Sale (S): 2,100 @ $101.77 · Sale (S): 9,000 @ $102.55 · Sale (S): 7,500 @ $103.48 · +11 moreEDGAR
2026-08-114Connaughton Bernadette — DirectorSale (S): 1,626 @ $102.80EDGAR
2026-07-094Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 1,923 @ $12.07 · Sale (S): 888 @ $79.28 · Sale (S): 1,035 @ $80.19 · Option exercise (M): 1,923 (derivative) @ $12.07EDGAR
2026-07-024RAMSAY DAVID A — EVP, PRESIDENT, DRUG DELIVERYOption exercise (M): 10,000 @ $0 · Tax withholding (F): 5,408 @ $78.27 · Option exercise (M): 10,000 (derivative) @ $0 · Grant/award (A): 16,232 (derivative) @ $0 · Grant/award (A): 39,823 (derivative) @ $0EDGAR
2026-07-024Snellgrove Darren — SVP, Chief Financial OfficerGrant/award (A): 41,554 (derivative) @ $0 · Grant/award (A): 127,432 (derivative) @ $0EDGAR
2026-07-024Connaughton Bernadette — DirectorSale (S): 1,000 @ $76.39 · Sale (S): 625 @ $77.21EDGAR
2026-06-304Krishnan Mahesh — DirectorOption exercise (M): 7,304 @ $38.46 · Sale (S): 7,304 @ $75 · Option exercise (M): 7,304 (derivative) @ $0EDGAR
2026-06-154Snyder Mark Howard — SVP, CHIEF LEGAL OFFICEROption exercise (M): 5,034 @ $0 · Tax withholding (F): 2,715 @ $69.50 · Option exercise (M): 5,034 (derivative) @ $0EDGAR
2026-06-034Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $12.07 · Sale (S): 1,610 @ $66.39 · Sale (S): 12,989 @ $67.41 · Sale (S): 5,401 @ $68.35 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 16,600 @ $66.31 · +9 moreEDGAR
2026-06-024Connaughton Bernadette — DirectorSale (S): 1,625 @ $66.21EDGAR
2026-05-134Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $12.07 · Sale (S): 9,725 @ $64.63 · Sale (S): 3,575 @ $65.46 · Sale (S): 6,700 @ $66.33 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 100 @ $67.85 · +12 moreEDGAR
2026-05-074Posard Matthew L. — DirectorGrant/award (A): 3,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0EDGAR
2026-05-074Krishnan Mahesh — DirectorGrant/award (A): 3,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0EDGAR
2026-05-074Lang James Paul — DirectorGrant/award (A): 3,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0EDGAR
2026-05-074Henderson Jeffrey William — DirectorGrant/award (A): 3,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0EDGAR
2026-05-074DUNCAN BARBARA GAYLE — DirectorGrant/award (A): 3,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0EDGAR
2026-05-074Connaughton Bernadette — DirectorGrant/award (A): 6,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0EDGAR
2026-05-054Connaughton Bernadette — DirectorSale (S): 1,625 @ $63.48EDGAR
2026-04-074Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 10,000 @ $12.07 · Sale (S): 5,900 @ $63.14 · Sale (S): 4,100 @ $64.02 · Option exercise (M): 10,000 (derivative) @ $12.07EDGAR
2026-04-024RAMSAY DAVID A — Interim CFOGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-04-024Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $12.07 · Sale (S): 19,000 @ $65.36 · Sale (S): 1,000 @ $65.71 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 15,800 @ $64.06 · Sale (S): 4,200 @ $64.89 · +2 moreEDGAR
2026-03-104Caudill Cortney — SVP, CHIEF OPERATING OFFICEROption exercise (M): 20,000 @ $33.51 · Sale (S): 17,900 @ $67.75 · Sale (S): 2,100 @ $68.25 · Option exercise (M): 1,546 @ $33.51 · Sale (S): 8,857 @ $67.64 · Option exercise (M): 20,000 (derivative) @ $33.51 · +1 moreEDGAR
2026-03-044Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $12.07 · Sale (S): 4,100 @ $69.20 · Sale (S): 15,322 @ $69.80 · Sale (S): 578 @ $70.46 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 13,481 @ $68.85 · +7 moreEDGAR
2026-02-244Caudill Cortney — SVP, CHIEF OPERATING OFFICEROption exercise (M): 2,666 @ $0 · Tax withholding (F): 1,037 @ $70.98 · Option exercise (M): 2,666 (derivative) @ $0EDGAR
2026-02-244Snyder Mark Howard — SVP, CHIEF LEGAL OFFICEROption exercise (M): 5,332 @ $0 · Tax withholding (F): 2,876 @ $70.98 · Option exercise (M): 7,011 @ $0 · Tax withholding (F): 3,782 @ $70.64 · Option exercise (M): 5,332 (derivative) @ $0 · Option exercise (M): 7,011 (derivative) @ $0EDGAR
2026-02-244LaBrosse Nicole — SVP, CHIEF FINANCIAL OFFICEROption exercise (M): 5,332 @ $0 · Tax withholding (F): 2,876 @ $70.98 · Option exercise (M): 6,688 @ $0 · Tax withholding (F): 3,608 @ $70.64 · Option exercise (M): 5,332 (derivative) @ $0 · Option exercise (M): 6,688 (derivative) @ $0EDGAR
2026-02-244Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 16,757 @ $0 · Tax withholding (F): 9,040 @ $70.98 · Option exercise (M): 22,436 @ $0 · Tax withholding (F): 12,104 @ $70.64 · Option exercise (M): 16,757 (derivative) @ $0 · Option exercise (M): 22,436 (derivative) @ $0EDGAR
2026-02-174Snyder Mark Howard — SVP, CHIEF LEGAL OFFICEROption exercise (M): 4,796 @ $0 · Tax withholding (F): 2,587 @ $79.44 · Option exercise (M): 12,016 @ $0 · Tax withholding (F): 6,481 @ $79.44 · Option exercise (M): 4,796 (derivative) @ $0 · Option exercise (M): 12,016 (derivative) @ $0EDGAR
2026-02-174LaBrosse Nicole — SVP, CHIEF FINANCIAL OFFICEROption exercise (M): 5,093 @ $0 · Tax withholding (F): 2,747 @ $79.44 · Option exercise (M): 5,329 @ $0 · Tax withholding (F): 2,874 @ $79.44 · Option exercise (M): 13,351 @ $0 · Tax withholding (F): 7,273 @ $79.44 · +3 moreEDGAR
2026-02-174Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 21,009 @ $0 · Tax withholding (F): 11,334 @ $79.44 · Option exercise (M): 16,875 @ $0 · Tax withholding (F): 9,104 @ $79.44 · Option exercise (M): 51,171 @ $0 · Tax withholding (F): 27,605 @ $79.44 · +3 moreEDGAR
2026-02-114Caudill Cortney — SVP, CHIEF OPERATING OFFICERGrant/award (A): 14,047 (derivative) @ $0 · Grant/award (A): 13,047 (derivative) @ $0 · Grant/award (A): 2,403 (derivative) @ $0 · Grant/award (A): 14,751 (derivative) @ $0EDGAR
2026-02-114Snyder Mark Howard — SVP, CHIEF LEGAL OFFICERGrant/award (A): 18,730 (derivative) @ $0 · Grant/award (A): 17,396 (derivative) @ $0 · Grant/award (A): 4,651 (derivative) @ $0 · Grant/award (A): 7,808 (derivative) @ $0 · Grant/award (A): 29,502 (derivative) @ $0EDGAR
2026-02-114LaBrosse Nicole — SVP, CHIEF FINANCIAL OFFICERGrant/award (A): 5,167 (derivative) @ $0 · Grant/award (A): 7,448 (derivative) @ $0 · Grant/award (A): 29,502 (derivative) @ $0EDGAR
2026-02-114Torley Helen — PRESIDENT AND CEO, DirectorGrant/award (A): 53,847 (derivative) @ $0 · Grant/award (A): 50,013 (derivative) @ $0 · Grant/award (A): 19,807 (derivative) @ $0 · Grant/award (A): 24,985 (derivative) @ $0 · Grant/award (A): 92,714 (derivative) @ $0EDGAR
2026-02-054Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $12.07 · Sale (S): 2,551 @ $74.88 · Sale (S): 9,659 @ $75.94 · Sale (S): 7,790 @ $76.73 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 9,900 @ $76.94 · +7 moreEDGAR
2026-01-064Lang James Paul — DirectorGrant/award (A): 889 @ $0 · Grant/award (A): 1,342 (derivative) @ $0EDGAR
2026-01-064Connaughton Bernadette — DirectorSale (S): 2,000 @ $70.25EDGAR
2026-01-064Snyder Mark Howard — SVP, CHIEF LEGAL OFFICEROption exercise (M): 7,611 @ $0 · Tax withholding (F): 4,243 @ $70.31 · Option exercise (M): 7,611 (derivative) @ $0EDGAR
2025-12-194Caudill Cortney — SVP, CHIEF OPERATING OFFICEROption exercise (M): 9,326 @ $0 · Sale (S): 4,263 @ $65.19 · Option exercise (M): 9,326 (derivative) @ $0EDGAR
2025-12-114Torley Helen — PRESIDENT AND CEO, DirectorGrant/award (A): 165,522 (derivative) @ $0EDGAR
2025-12-014Connaughton Bernadette — DirectorSale (S): 829 @ $71.60EDGAR
2025-12-014Torley Helen — PRESIDENT AND CEO, DirectorGift (G): 25,000 @ $0 · Option exercise (M): 16,569 @ $8.11 · Sale (S): 10,406 @ $68.51 · Sale (S): 5,402 @ $69.44 · Sale (S): 500 @ $70.36 · Sale (S): 261 @ $71.60 · +1 moreEDGAR
2025-11-124Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $8.11 · Sale (S): 19,900 @ $68.71 · Sale (S): 100 @ $69.30 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 4,500 @ $67.89 · Sale (S): 4,000 @ $68.80 · +8 moreEDGAR
2025-11-124Connaughton Bernadette — DirectorSale (S): 2,000 @ $68.48EDGAR
2025-10-064Caudill Cortney — SVP, CHIEF OPERATING OFFICERGrant/award (A): 9,031 (derivative) @ $0 · Grant/award (A): 3,625 (derivative) @ $0EDGAR
2025-10-034Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $8.11 · Sale (S): 11,705 @ $75.11 · Sale (S): 8,295 @ $75.69 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 6,600 @ $70.51 · Sale (S): 10,200 @ $71.28 · +11 moreEDGAR
2025-10-014Connaughton Bernadette — DirectorSale (S): 1,500 @ $75.09 · Sale (S): 500 @ $75.70EDGAR
2025-09-234LaBrosse Nicole — SVP, CHIEF FINANCIAL OFFICERSale (S): 1,913 @ $77.83 · Sale (S): 314 @ $78.67EDGAR
2025-09-114LaBrosse Nicole — SVP, CHIEF FINANCIAL OFFICEROption exercise (M): 11,271 @ $12.07 · Option exercise (M): 1,135 @ $12.49 · Sale (S): 6,760 @ $75.29 · Sale (S): 13,240 @ $75.93 · Option exercise (M): 11,271 (derivative) @ $0 · Option exercise (M): 1,135 (derivative) @ $0EDGAR
2025-09-044Torley Helen — PRESIDENT AND CEO, DirectorOption exercise (M): 20,000 @ $8.11 · Sale (S): 300 @ $72.48 · Sale (S): 16,288 @ $73.70 · Sale (S): 3,412 @ $74.15 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 9,500 @ $74.22 · +8 moreEDGAR

Recent 8-K events — HALOZYME THERAPEUTICS, INC.

FiledFormItems reportedSource
2026-08-188-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-04-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-248-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-178-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=HALO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →